Evidence map›Paper›PMID 40697846›Full record

ArticleFrontiers in public health2025

Assessment of the efficiency and effectiveness of health care systems in European Union countries before and during the COVID-19 pandemic.

Marek Biernacki

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Marek BiernackiDepartment of Mathematics and Cybernetics, Wrocław University of Economics and Business, Wrocław, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The aim of this study was to determine the extent to which the national healthcare systems of European Union countries used their medical potential in the fight against COVID-19. The analyzed period covered the years before the pandemic 2009-2018 and the COVID-19 pandemic. The analysis was conducted for all European Union's countries. It concerned the evaluation not only of the effectiveness of treatment, but also of the efficiency, i.e., the use of resources in healthcare systems. Study design: Descriptive and analytical study on EUROSTAT data, Health Consumer Powerhouse, OECD Health Statistics, European Health Interview Survey (EHIS) and World Health Organization (WHO). Methodology: An index was proposed to measure the quality of healthcare systems' activities, which simultaneously assesses the effectiveness and efficiency of treatment. The treatment results depend not only on management, but also on financial resources. EHCI, HLY, % of unmet medical needs were used to assess the effectiveness of treatment. Efficiency was calculated using with the DEA method based on total healthcare expenditure per capita at purchasing power parity. The final assessment is based on the difference in the index value from the pandemic period and before the COVID-19 pandemic. Results: The healthcare systems of small EU countries coped most effectively and efficiently during the COVID-19 pandemic: Denmark (0.6), Estonia (0.5), Austria (0.5), Slovenia (0.3), and the Czech Republic (0.3). However, large and non-rich EU countries fared much worse: Spain (-0.8), Hungary (-0.7) and Poland (-0.4). This group also unexpectedly included the Netherlands (-0.3)-a small, wealthy country that coped poorly with the challenges posed by the COVID-19 pandemic. Conclusion: Based on the analysis carried out in this paper, it can be concluded that the optimal (efficient and effective) use of medical resources did not depend only on the state of ownership and technological advancement of healthcare systems (!). The involvement of medical staff, society, and decisions of state authorities were equally significant.

Indexed as

COVID-19Delivery of Health CareEfficiency, OrganizationalEuropean UnionQuality of Health CareHealth ExpendituresHumansPandemicsSARS-CoV-2COVID-19effectivenessexcess deathhealthcare systemstreatment efficiency

Identifiers

PMID40697846
PMCPMC12279879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.